Prelude Capital Management’s Biote Corp. Warrant BTMDW Stock Holding History

Prelude Capital Management’s Portfolio BTMDW Stock Details BTMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-62,500	Closed	-$21K	–	1766
2022 Q3	$21K	Hold	62,500	–	–	﹤0.01%	1272
2022 Q2	$27K	Sell	62,500 -42,667	-41%	-$23K	﹤0.01%	1517
2022 Q1	$58K	Buy	105,167 +42,667	+68%	+$20.2K	﹤0.01%	1482
2021 Q4	$45K	Sell	62,500 -1,800	-3%	-$1.45K	﹤0.01%	1785
2021 Q3	$52K	Hold	64,300	–	–	﹤0.01%	1551
2021 Q2	$68K	Buy	+64,300	New	+$55.6K	﹤0.01%	1503

Other funds holding BTMDW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

AGC

Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

Prelude Capital Management's BTMDW Position: Q4 2022 in Review

Prelude Capital Management sold out of Biote Corp. Warrant (BTMDW) in Q4 2022, closing a stake of 62,500 shares — an estimated $21K sold.

Prelude Capital Management first reported a position in BTMDW in Q2 2021 and held it in 6 quarters. The position peaked at $68K in Q2 2021. 39 funds tracked by Wall St. Rank hold BTMDW as of Q4 2022.

Prelude Capital Management reported no remaining Biote Corp. Warrant position as of Q4 2022 after selling out during the quarter.
Prelude Capital Management sold 62,500 Biote Corp. Warrant shares in Q4 2022, an estimated $21K.
Prelude Capital Management first reported a position in Biote Corp. Warrant in Q2 2021 and held it in 6 quarters.
Prelude Capital Management's Biote Corp. Warrant position peaked at $68K in Q2 2021.
39 funds tracked by Wall St. Rank held Biote Corp. Warrant as of Q4 2022.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.